Nakeshia "Keshia" Baskerville

Associate Director Clinical Operations at Apogee Therapeutics

Nakeshia "Keshia" Baskerville has had a diverse range of work experience in the clinical operations field. Nakeshia "Keshia" currently holds the position of Associate Director Clinical Operations at Apogee Therapeutics, starting in April 2023. Prior to this, they worked as a Clinical Operations Consultant for one year at their own consultancy from June 2022 to April 2023.

Before starting their own consultancy, Baskerville held various roles at Arena Pharmaceuticals, Inc. from September 2018 to May 2022. Nakeshia "Keshia" started as a Clinical Trial Manager and later became a Senior Clinical Trial Manager.

In 2018, they also worked as a Clinical Operations Consultant for a brief period at Regulus Therapeutics. Before that, they served as a Clinical Research Associate at Synteract from August 2017 to March 2018.

Baskerville has extensive experience in the field, having worked as the Manager of Clinical Operations at eStudySite for over eight years, from February 2009 to August 2017. Nakeshia "Keshia" also gained earlier experience as a Medical Administrative Assistant at arthritis consultants of north county from September 2005 to April 2007.

Nakeshia "Keshia" Baskerville obtained a Bachelor's Degree in Health Services Management from Independence University, studying from 2014 to 2016. In terms of additional certifications, they obtained a certificate in Speaking Confidently and Effectively from LinkedIn in October 2021. Nakeshia "Keshia" also holds a certificate in Medical Administrative Assistant from Pima Medical Institute, obtained in September 2005. Additionally, they are a Certified Clinical Research Coordinator from NCC ACRP - Northern California Chapter of Association of Clinical Research Professionals, although the specific month and year of obtaining this certification are unspecified.

Links

Previous companies

Regulus Therapeutics logo
Arena Pharmaceuticals logo

Timeline

  • Associate Director Clinical Operations

    April, 2023 - present

View in org chart